
I-Mab IMAB.O:
I-MAB STRENGTHENS GIVASTOMIG INTELLECTUAL PROPERTY PORTFOLIO THROUGH ACQUISITION OF BRIDGE HEALTH
I-MAB - BRIDGE HEALTH SHAREHOLDERS MAY RECEIVE UP TO $3.875 MILLION IN MILESTONES
I-MAB - TO PAY $1.8 MILLION UPFRONT AND $1.2 MILLION THROUGH 2027